Ignite Creation Date:
2024-07-17 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06484855
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-26
Brief Title:
Safety and Tolerability of IBI355 in Patients With Primary Sjogrens Syndrome
Sponsor:
Innovent Biologics Suzhou Co Ltd
Organization:
Innovent Biologics Suzhou Co Ltd
Organization Data
Organization:
Innovent Biologics Suzhou Co Ltd
Class:
INDUSTRY
Study ID:
CIBI355A102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Innovent Biologics Suzhou Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None